ONTOLOGY REPORT - ANNOTATIONS
Term: cladribine
Accession: CHEBI:567361
browse the term
Definition: 2'-Deoxyadenosine in which the hydrogen at position 2 on the purine ring has been substituted by chlorine. It inhibits the synthesis and repair of DNA, particularly in lymphocytes and monocytes, and is used as an antimetabolite antineoplastic drug for the treatment of lymphoid malignancies including hairy-cell leukaemia and chronic lymphocytic leukaemia.
Synonyms: related_synonym: (2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol; 2-CdA; 2-chloro-2'-deoxy-beta-adenosine; 2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine; 2-chloro-deoxyadenosine; 2-chlorodeoxyadenosine; 2ClAdo; C10H12ClN5O3; CldAdo; InChI=1S/C10H12ClN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,6+/m0/s1; InChIKey=PTOAARAWEBMLNO-KVQBGUIXSA-N; Nc1nc(Cl)nc2n(cnc12)[C@H]1C[C@H](O)[C@@H](CO)O1; cladribina; cladribinum
alt_id: CHEBI:31407; CHEBI:568373
xref_casrn: 4291-63-8
xref: Beilstein:624220 "Beilstein Registry Number"; ChEMBL:17526755 "PubMed citation"; ChEMBL:18570408 "PubMed citation"; ChEMBL:567361 "ChEMBL COMPOUND"; ChEMBL:568373 "ChEMBL COMPOUND"; ChemIDplus:4291-63-8 "CAS Registry Number"; DrugBank:DB00242 "DrugBank"; KEGG DRUG:4291-63-8 "CAS Registry Number"; KEGG DRUG:D01370 "KEGG DRUG"
xref_mesh: MESH:D017338
xref: Patent:EP173059 "Patent"; Patent:US4760137 "Patent"; Wikipedia:Cladribine "Wikipedia"
cladribine
G
Bcl2
B-cell CLL/lymphoma 2
multiple interactions
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
multiple interactions
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
decreases expression
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Birc3
baculoviral IAP repeat-containing 3
multiple interactions
ISO
8
4,682,202
4,696,856
RGD:6480464
CTD
G
Casp3
caspase 3
increases activity
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
multiple interactions
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
multiple interactions
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
increases activity
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
increases activity
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
increases activity
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp6
caspase 6
multiple interactions
ISO
2
227,361,538
227,373,844
RGD:6480464
CTD
G
Casp6
caspase 6
increases activity
ISO
2
227,361,538
227,373,844
RGD:6480464
CTD
G
Casp6
caspase 6
increases activity
ISO
2
227,361,538
227,373,844
RGD:6480464
CTD
G
Casp7
caspase 7
multiple interactions
ISO
1
262,689,300
262,721,591
RGD:6480464
CTD
G
Casp7
caspase 7
increases activity
ISO
1
262,689,300
262,721,591
RGD:6480464
CTD
G
Casp8
caspase 8
increases activity
ISO
9
57,389,353
57,437,803
RGD:6480464
CTD
G
Casp8
caspase 8
multiple interactions
ISO
9
57,389,353
57,437,803
RGD:6480464
CTD
G
Casp8
caspase 8
multiple interactions
ISO
9
57,389,353
57,437,803
RGD:6480464
CTD
G
Casp8
caspase 8
increases activity
ISO
9
57,389,353
57,437,803
RGD:6480464
CTD
G
Casp8
caspase 8
increases cleavage
ISO
9
57,389,353
57,437,803
RGD:6480464
CTD
G
Casp8
caspase 8
multiple interactions
ISO
9
57,389,353
57,437,803
RGD:6480464
CTD
G
Casp8
caspase 8
increases activity
ISO
9
57,389,353
57,437,803
RGD:6480464
CTD
G
Casp8
caspase 8
increases activity
ISO
9
57,389,353
57,437,803
RGD:6480464
CTD
G
Casp8
caspase 8
increases activity
ISO
9
57,389,353
57,437,803
RGD:6480464
CTD
G
Casp9
caspase 9, apoptosis-related cysteine peptidase
multiple interactions
ISO
5
160,704,234
160,721,796
RGD:6480464
CTD
G
Casp9
caspase 9, apoptosis-related cysteine peptidase
multiple interactions
ISO
5
160,704,234
160,721,796
RGD:6480464
CTD
G
Casp9
caspase 9, apoptosis-related cysteine peptidase
increases activity
ISO
5
160,704,234
160,721,796
RGD:6480464
CTD
G
Casp9
caspase 9, apoptosis-related cysteine peptidase
increases activity
ISO
5
160,704,234
160,721,796
RGD:6480464
CTD
G
Daxx
death-domain associated protein
multiple interactions
ISO
20
5,121,854
5,127,601
RGD:6480464
CTD
G
Diablo
diablo, IAP-binding mitochondrial protein
multiple interactions
ISO
12
34,196,347
34,209,633
RGD:6480464
CTD
G
Il4
interleukin 4
increases expression
ISO
10
39,074,582
39,080,134
RGD:6480464
CTD
G
Lmnb1
lamin B1
multiple interactions
ISO
18
52,470,605
52,508,022
RGD:6480464
CTD
G
Lmnb1
lamin B1
increases cleavage
ISO
18
52,470,605
52,508,022
RGD:6480464
CTD
G
LOC100360940
diablo-like
multiple interactions
ISO
5
148,562,065
148,563,619
RGD:6480464
CTD
G
Mll
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)
increases response to substance
ISO
8
47,759,175
47,834,586
RGD:6480464
CTD
G
Nt5c1a
5'-nucleotidase, cytosolic IA
decreases response to substance
ISO
5
142,509,257
142,524,280
RGD:6480464
CTD
G
Nt5c1a
5'-nucleotidase, cytosolic IA
multiple interactions
ISO
5
142,509,257
142,524,280
RGD:6480464
CTD
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
13
96,309,670
96,341,486
RGD:6480464
CTD
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
13
96,309,670
96,341,486
RGD:6480464
CTD
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
13
96,309,670
96,341,486
RGD:6480464
CTD
G
Pawr
PRKC, apoptosis, WT1, regulator
multiple interactions
ISO
7
47,040,162
47,119,613
RGD:6480464
CTD
G
Stat3
signal transducer and activator of transcription 3 (acute-phase response factor)
increases phosphorylation
ISO
10
89,821,078
89,872,970
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
increases expression
ISO
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Xiap
X-linked inhibitor of apoptosis
multiple interactions
ISO
X
3,011,520
3,047,798
RGD:6480464
CTD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest